Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress

被引:63
作者
Jaimes, Edgar A. [1 ,2 ]
Hua, Ping [1 ]
Tian, Run-Xia [3 ]
Raij, Leopoldo [3 ,4 ]
机构
[1] Univ Alabama Birmingham, Div Renal, Birmingham, AL 35294 USA
[2] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA
[3] Univ Miami, Miller Sch Med, Div Renal, Miami, FL 33136 USA
[4] Miami Vet Affairs Med Ctr, Miami, FL USA
基金
美国国家卫生研究院;
关键词
diabetes; prostaglandins; reactive oxygen species; nitric oxide; NITRIC-OXIDE SYNTHASE; SUPEROXIDE ANION PRODUCTION; STAGE RENAL-DISEASE; INSULIN-RESISTANCE; PROGRESSION; KIDNEY; CYCLOOXYGENASE-2; AUTOREGULATION; HYPERTENSION; ALBUMINURIA;
D O I
10.1152/ajprenal.00248.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Jaimes EA, Hua P, Tian R-X, Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol 298: F125-F132, 2010. First published October 28, 2009; doi:10.1152/ajprenal.00248.2009.-Glomerular endothelial cells (GEC) are strategically situated within the capillary loop and adjacent to the glomerular mesangium. GEC serve as targets of metabolic, biochemical, and hemodynamic signals that regulate the glomerular microcirculation. Unequivocally, hyperglycemia, hypertension, and the local renin-angiotensin system partake in the initiation and progression of diabetic nephropathy (DN). Whether free fatty acids (FFA) and reactive oxygen species (ROS) that have been associated with the endothelial dysfunction of diabetic macrovascular disease also contribute to DN is not known. Since endothelial cells from different organs and from different species may display different phenotypes, we employed human GEC to investigate the effect of high glucose (22.5 mmol/l), FFA (800 mu mol/l), and angiotensin II (ANG II; 10(-7) mol/l) on the genesis of ROS and their effects on endothelial nitric oxide synthase (eNOS), cyclooxygenase-2 (COX-2), and the synthesis of prostaglandins (PGs). We demonstrated that high glucose but not high FFA increased the expression of a dysfunctional eNOS as well as increased ROS from NADPH oxidase (100%) and likely from uncoupled eNOS. ANG II also induced ROS from NADPH oxidase. High glucose and ANG II upregulated (100%) COX-2 via ROS and significantly increased the synthesis of prostacyclin (PGI(2)) by 300%. In contrast, FFA did not upregulate COX-2 but increased PGI(2) (500%). These novel studies are the first in human GEC that characterize the differential role of FFA, hyperglycemia, and ANG II on the genesis of ROS, COX-2, and PGs and their interplay in the early stages of hyperglcyemia.
引用
收藏
页码:F125 / F132
页数:8
相关论文
共 48 条
[1]   RENAL AUTOREGULATION - MODELS COMBINING TUBULOGLOMERULAR FEEDBACK AND MYOGENIC RESPONSE [J].
AUKLAND, K ;
OIEN, AH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (04) :F768-F783
[2]   The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes - Results from Metascreen, a multicenter diabetes clinic-based survey [J].
Bonadonna, Riccarcdo C. ;
Cucinotta, Domenico ;
Fedele, Domenico ;
Riccardi, Gabriele ;
Tiengo, Antonio .
DIABETES CARE, 2006, 29 (12) :2701-2707
[3]   Cyclooxygenase 2 and the kidney [J].
Breyer, MD ;
Harris, RC .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (01) :89-98
[4]  
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
[5]   Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation [J].
Du, XL ;
Edelstein, D ;
Obici, S ;
Higham, N ;
Zou, MH ;
Brownlee, M .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (04) :1071-1080
[6]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[7]   End-stage renal disease in the United States: An update from the United States renal data system [J].
Foley, Robert N. ;
Collins, Allan J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (10) :2644-2648
[8]   THE COURSE OF KIDNEY-FUNCTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY [J].
GALL, MA ;
NIELSEN, FS ;
SMIDT, UM ;
PARVING, HH .
DIABETOLOGIA, 1993, 36 (10) :1071-1078
[9]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[10]  
Hink U, 2001, CIRC RES, V88, pE14